Azabicyclic alkanes are important building blocks in drug discovery. Several drug substances possessing an azabicyclic alkane moiety, including sabcomeline [1], varenicline [2], granisetron [3] and cevimeline [4] have been launched (Chart 1). In addition, numerous reports on biologically active substances containing an azabicyclic alkane have appeared in the literature, with an emphasis towards CNS-related targets, such as serotonin 5-HT3 ...